{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:49:55Z","timestamp":1791319795276,"version":"4.3.1"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001782","name":"The University of Melbourne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001782","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011371","name":"Royal Australasian College of Surgeons","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011371","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ejso.2026.112184","type":"journal-article","created":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T22:31:10Z","timestamp":1791066670000},"page":"112184","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Patient selection in those undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases \u2013 systematic review and meta-analysis of prognostic factors in large cohorts"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3180-383X","authenticated-orcid":false,"given":"Amanda","family":"Liesegang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halle","family":"Powell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8395-7355","authenticated-orcid":false,"given":"Anshini","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne","family":"Tie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9283-9978","authenticated-orcid":false,"given":"Nicholas","family":"Clemons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0593-2662","authenticated-orcid":false,"given":"Michael","family":"Michael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2505-1643","authenticated-orcid":false,"given":"Glen","family":"Guerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Heriot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ejso.2026.112184_bib1","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/S1470-2045(16)30500-9","article-title":"Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the analysis and research in cancers of the digestive system (ARCAD) database","volume":"17","author":"Franko","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2026.112184_bib2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.critrevonc.2016.01.017","article-title":"Progress in treatments for colorectal cancer peritoneal metastases during the years 2010-2015. A systematic review","volume":"100","author":"Baratti","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"issue":"20","key":"10.1016\/j.ejso.2026.112184_bib3","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1200\/JCO.2003.04.187","article-title":"Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer","volume":"21","author":"Verwaal","year":"2003","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2026.112184_bib4","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S1470-2045(20)30599-4","article-title":"Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial","volume":"22","author":"Qu\u00e9net","year":"2021","journal-title":"Lancet Oncol"},{"issue":"13","key":"10.1016\/j.ejso.2026.112184_bib5","doi-asserted-by":"crossref","first-page":"9688","DOI":"10.1245\/s10434-025-18147-2","article-title":"Quality of life and minimal clinically important difference in colorectal cancer patients undergoing hyperthermic intraperitoneal chemotherapy: a large prospective cohort study","volume":"32","author":"Chiu","year":"2025","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"10.1016\/j.ejso.2026.112184_bib6","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1111\/codi.15003","article-title":"Prognostic factors influencing survival in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for isolated colorectal peritoneal metastases: a systematic review and meta-analysis","volume":"22","author":"Narasimhan","year":"2020","journal-title":"Colorectal Dis"},{"issue":"5","key":"10.1016\/j.ejso.2026.112184_bib7","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/bjs5.50179","article-title":"Meta-analysis of prognostic factors for patients with colorectal peritoneal metastasis undergoing cytoreductive surgery and heated intraperitoneal chemotherapy","volume":"3","author":"Hallam","year":"2019","journal-title":"BJS Open"},{"issue":"6","key":"10.1016\/j.ejso.2026.112184_bib8","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1097\/SLA.0000000000001593","article-title":"Clinicopathological parameters in patient selection for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer metastases: a meta-analysis","volume":"263","author":"Kwakman","year":"2016","journal-title":"Ann Surg"},{"issue":"11","key":"10.1016\/j.ejso.2026.112184_bib9","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/j.ejso.2019.06.020","article-title":"Colic and rectal tumors with peritoneal metastases treated with cytoreductive surgery and HIPEC: one homogeneous condition or two different diseases? A systematic review and meta-analysis","volume":"45","author":"Tonello","year":"2019","journal-title":"Eur J Surg Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2026.112184_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2024.108474","article-title":"Effect of RAS and BRAF mutations on peritoneal metastasis risk and cytoreductive surgery\/hyperthermic intraperitoneal chemotherapy efficacy in colorectal cancer: a systematic review and meta-analysis","volume":"50","author":"Gao","year":"2024","journal-title":"Eur J Surg Oncol"},{"issue":"10","key":"10.1016\/j.ejso.2026.112184_bib11","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1016\/j.ejso.2022.06.014","article-title":"The impact of molecular and mismatch repair status on the survival outcomes of surgically treated patients with colorectal peritoneal metastases","volume":"48","author":"Flood","year":"2022","journal-title":"Eur J Surg Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2026.112184_bib12","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1245\/s10434-021-11045-3","article-title":"Microsatellite and RAS\/RAF mutational status as prognostic factors in colorectal peritoneal metastases treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC)","volume":"29","author":"Tonello","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2026.112184_bib13","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s11605-022-05501-y","article-title":"Pelvic peritonectomy poorly affects outcomes in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal metastases","volume":"27","author":"Mor","year":"2023","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.ejso.2026.112184_bib14","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jss.2019.10.001","article-title":"The association of tumor laterality and survival after cytoreduction for colorectal carcinomatosis","volume":"248","author":"Blakely","year":"2020","journal-title":"J Surg Res"},{"issue":"2","key":"10.1016\/j.ejso.2026.112184_bib19","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/SLA.0b013e3182263933","article-title":"Results of two bi-institutional prospective studies using intraperitoneal oxaliplatin with or without irinotecan during HIPEC after cytoreductive surgery for colorectal carcinomatosis","volume":"254","author":"Quenet","year":"2011","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.ejso.2026.112184_bib35","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ejso.2010.10.014","article-title":"Prognostic factors and oncologic outcome in 146 patients with colorectal peritoneal carcinomatosis treated with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy: italian multicenter study S.I.T.I.L.O","volume":"37","author":"Cavaliere","year":"2011","journal-title":"Eur J Surg Oncol"},{"issue":"7","key":"10.1016\/j.ejso.2026.112184_bib17","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1097\/DCR.0000000000000149","article-title":"Postoperative complications after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy affect long-term outcome of patients with peritoneal metastases from colorectal cancer: a two-center study of 101 patients","volume":"57","author":"Baratti","year":"2014","journal-title":"Dis Colon Rectum"},{"issue":"11","key":"10.1016\/j.ejso.2026.112184_bib36","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.ejso.2014.06.006","article-title":"Modified selection criteria for complete cytoreductive surgery plus HIPEC based on peritoneal cancer index and small bowel involvement for peritoneal carcinomatosis of colorectal origin","volume":"40","author":"Elias","year":"2014","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2026.112184_bib37","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/jso.23784","article-title":"Poor outcome after cytoreductive surgery and HIPEC for colorectal peritoneal carcinomatosis with signet ring cell histology","volume":"111","author":"van Oudheusden","year":"2015","journal-title":"J Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2026.112184_bib38","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ejso.2015.01.018","article-title":"Trends in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of synchronous peritoneal carcinomatosis of colorectal origin in the Netherlands","volume":"41","author":"Razenberg","year":"2015","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2026.112184_bib39","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1245\/s10434-015-4627-8","article-title":"Linear relationship of peritoneal cancer index and survival in patients with peritoneal metastases from colorectal cancer","volume":"23","author":"Faron","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"10.1016\/j.ejso.2026.112184_bib40","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/jso.24248","article-title":"What made hyperthermic intraperitoneal chemotherapy an effective curative treatment for peritoneal surface malignancy: a 25-year experience with 1,125 procedures","volume":"113","author":"Passot","year":"2016","journal-title":"J Surg Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2026.112184_bib41","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.ejso.2016.03.014","article-title":"Histological subtype and systemic metastases strongly influence treatment and survival in patients with synchronous colorectal peritoneal metastases","volume":"42","author":"Simkens","year":"2016","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2026.112184_bib42","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/jso.24290","article-title":"Complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastasis in Norway: prognostic factors and oncologic outcome in a national patient cohort","volume":"114","author":"Froysnes","year":"2016","journal-title":"J Surg Oncol"},{"issue":"11","key":"10.1016\/j.ejso.2026.112184_bib43","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/ans.13152","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: long-term results at St george hospital, Australia","volume":"86","author":"Alzahrani","year":"2016","journal-title":"ANZ J Surg"},{"issue":"4","key":"10.1016\/j.ejso.2026.112184_bib44","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1245\/s10434-016-5689-y","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion in adolescent and young adults with peritoneal metastases","volume":"24","author":"Dhir","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2026.112184_bib45","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejca.2018.04.015","article-title":"Peritoneal and extraperitoneal relapse after previous curative treatment of peritoneal metastases from colorectal cancer: what survival can we expect?","volume":"100","author":"Gelli","year":"2018","journal-title":"Eur J Cancer"},{"issue":"11","key":"10.1016\/j.ejso.2026.112184_bib46","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/j.ejso.2018.08.012","article-title":"Prolonged perioperative thoracic epidural analgesia may improve survival after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: a comparative study","volume":"44","author":"Lorimier","year":"2018","journal-title":"Eur J Surg Oncol"},{"issue":"7","key":"10.1016\/j.ejso.2026.112184_bib47","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1245\/s10434-019-07294-y","article-title":"Impact of synchronous versus metachronous onset of colorectal peritoneal metastases on survival outcomes after cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC): a multicenter, retrospective, observational study","volume":"26","author":"Hentzen","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2026.112184_bib48","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1245\/s10434-019-07255-5","article-title":"Does primary tumor side matter in patients with metastatic Colon cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy?","volume":"26","author":"Kelly","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2026.112184_bib49","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12957-020-1784-4","article-title":"The importance of synchronicity in the management of colorectal peritoneal metastases with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"18","author":"Wong","year":"2020","journal-title":"World J Surg Oncol"},{"issue":"8","key":"10.1016\/j.ejso.2026.112184_bib50","doi-asserted-by":"crossref","first-page":"903","DOI":"10.4251\/wjgo.v12.i8.903","article-title":"Comparison of hyperthermic intraperitoneal chemotherapy regimens for treatment of peritoneal-metastasized colorectal cancer","volume":"12","author":"Spiegelberg","year":"2020","journal-title":"World J Gastrointest Oncol"},{"issue":"10 Pt A","key":"10.1016\/j.ejso.2026.112184_bib51","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/j.ejso.2020.04.018","article-title":"Long-term survival after hyperthermic intraperitoneal chemotherapy using mitomycin C or oxaliplatin in colorectal cancer patients with synchronous peritoneal metastases: a nationwide comparative study","volume":"46","author":"Bakkers","year":"2020","journal-title":"Eur J Surg Oncol"},{"issue":"12","key":"10.1016\/j.ejso.2026.112184_bib18","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1016\/j.ejso.2020.07.039","article-title":"Patients with colorectal peritoneal metastases and high peritoneal cancer index May benefit from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"46","author":"Birgisson","year":"2020","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2026.112184_bib52","first-page":"1260","article-title":"Mitomycin-C versus oxaliplatin during cytoreductive surgery and HIPEC for peritoneal metastases secondary to colorectal carcinoma: a retrospective analysis","volume":"26","author":"Spiliotis","year":"2021","journal-title":"J Buon"},{"issue":"8","key":"10.1016\/j.ejso.2026.112184_bib53","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1093\/jnci\/djab001","article-title":"Site of recurrence and survival after surgery for colorectal peritoneal metastasis","volume":"113","author":"Breuer","year":"2021","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"10.1016\/j.ejso.2026.112184_bib54","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1016\/j.ejso.2021.05.046","article-title":"Direct surgery with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for patients with colorectal peritoneal metastases","volume":"47","author":"Ljunggren","year":"2021","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2026.112184_bib55","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ejso.2022.07.019","article-title":"Patterns and timing of recurrence following CRS and HIPEC in colorectal cancer peritoneal metastasis","volume":"49","author":"Hassan","year":"2023","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2026.112184_bib56","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ejso.2021.08.027","article-title":"The impact of postoperative complications following cytoreductive surgery combined with oxaliplatin based heated intraperitoneal chemotherapy","volume":"48","author":"Verwaal","year":"2022","journal-title":"Eur J Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2026.112184_bib27","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/s41416-021-01620-6","article-title":"Impact of KRAS, BRAF and microsatellite instability status after cytoreductive surgery and HIPEC in a national cohort of colorectal peritoneal metastasis patients","volume":"126","author":"Larsen","year":"2022","journal-title":"Br J Cancer"},{"issue":"8","key":"10.1016\/j.ejso.2026.112184_bib57","doi-asserted-by":"crossref","first-page":"5256","DOI":"10.1245\/s10434-022-11718-7","article-title":"In patients undergoing CRS\/HIPEC for colorectal adenocarcinoma with peritoneal metastases, presence of ascites on computed tomography imaging is not a prognostic marker for survival","volume":"29","author":"Said","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"10.1016\/j.ejso.2026.112184_bib58","doi-asserted-by":"crossref","first-page":"6566","DOI":"10.1245\/s10434-022-11805-9","article-title":"Survival outcomes after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in patients with synchronous versus metachronous onset of peritoneal metastases of colorectal carcinoma","volume":"29","author":"Dietz","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2026.112184_bib59","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1111\/ans.17761","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases in an elderly population: outcomes from a single centre","volume":"92","author":"Flood","year":"2022","journal-title":"ANZ J Surg"},{"issue":"12","key":"10.1016\/j.ejso.2026.112184_bib60","doi-asserted-by":"crossref","first-page":"7568","DOI":"10.1245\/s10434-022-12221-9","article-title":"Peritoneal metastases of colorectal origin treated with complete cytoreduction and hyperthermic intraperitoneal chemotherapy: the efficiency of mitomycin C","volume":"29","author":"Delhorme","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2026.112184_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.suronc.2022.101848","article-title":"Long-term outcomes of elderly patients with peritoneal metastases of colorectal origin after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"44","author":"Weksler","year":"2022","journal-title":"Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2026.112184_bib62","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41416-022-02037-5","article-title":"Age alone is not a barrier to efficacy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: analysis of 1138 patients from the UK and Ireland colorectal peritoneal metastases registry","volume":"128","author":"Kelly","year":"2023","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.ejso.2026.112184_bib63","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1245\/s10434-022-12704-9","article-title":"RAS mutation status should not be used to predict outcome from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases","volume":"30","author":"Bhullar","year":"2023","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"10.1016\/j.ejso.2026.112184_bib64","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.21873\/anticanres.16530","volume":"43","author":"Barat","year":"2023","journal-title":"Anticancer Res"},{"issue":"11","key":"10.1016\/j.ejso.2026.112184_bib65","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1007\/s11605-023-05833-3","article-title":"Perioperative and oncological outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal metastasis of rectal origin","volume":"27","author":"Benvenisti","year":"2023","journal-title":"J Gastrointest Surg"},{"issue":"1","key":"10.1016\/j.ejso.2026.112184_bib66","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/JS9.0000000000000809","article-title":"Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus R0 resection for resectable colorectal cancer with peritoneal metastases and low peritoneal cancer index scores: a collaborative observational study from Korea and Japan","volume":"110","author":"Kitaguchi","year":"2024","journal-title":"Int J Surg"},{"issue":"3","key":"10.1016\/j.ejso.2026.112184_bib20","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1245\/s10434-023-14608-8","article-title":"Actual 5-Year survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for patients with peritoneal carcinomatosis of colorectal origin","volume":"31","author":"Sarfaty","year":"2024","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2026.112184_bib67","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/wjs.12080","article-title":"Extremely high peritoneal cancer index in colorectal peritoneal metastases demonstrates safety and overall survival benefit in selected patients undergoing cytoreductive surgery and heated intraperitoneal chemotherapy","volume":"48","author":"Ben-Yaacov","year":"2024","journal-title":"World J Surg"},{"issue":"3","key":"10.1016\/j.ejso.2026.112184_bib68","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16030631","article-title":"Recurrence and survival following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for synchronous and metachronous peritoneal metastases of colorectal origin","volume":"16","author":"Nielsen","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.ejso.2026.112184_bib31","doi-asserted-by":"crossref","DOI":"10.1093\/bjsopen\/zrae017","article-title":"Hyperthermic intraperitoneal chemotherapy in colorectal cancer","volume":"8","author":"Fisher","year":"2024","journal-title":"BJS Open"},{"issue":"9","key":"10.1016\/j.ejso.2026.112184_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2023.07.002","article-title":"A narrative review of what can HIPEC do","volume":"49","author":"Sugarbaker","year":"2023","journal-title":"Eur J Surg Oncol"},{"issue":"2b","key":"10.1016\/j.ejso.2026.112184_bib16","first-page":"1501","article-title":"Heat penetration in locally applied hyperthermia in the abdomen during intra-operative hyperthermic intraperitoneal chemotherapy","volume":"23","author":"van Ruth","year":"2003","journal-title":"Anticancer Res"},{"issue":"8","key":"10.1016\/j.ejso.2026.112184_bib21","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1245\/s10434-019-07378-9","article-title":"RAS mutation decreases overall survival after optimal cytoreductive surgery and hyperthermic intraperitoneal chemotherapy of colorectal peritoneal metastasis: a modification proposal of the peritoneal surface disease severity score","volume":"26","author":"Arjona-Sanchez","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"10.1016\/j.ejso.2026.112184_bib22","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1007\/s11605-021-05073-3","article-title":"Clinical and molecular features in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinosis from colorectal cancer","volume":"25","author":"Di Giorgio","year":"2021","journal-title":"J Gastrointest Surg"},{"issue":"7","key":"10.1016\/j.ejso.2026.112184_bib23","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1002\/jso.26439","article-title":"Exploring the prognostic and therapeutic utility of expanded mutation profiling in appendix peritoneal metastasis managed with CRS\/HIPEC","volume":"123","author":"Zhang","year":"2021","journal-title":"J Surg Oncol"},{"issue":"7","key":"10.1016\/j.ejso.2026.112184_bib24","doi-asserted-by":"crossref","first-page":"4459","DOI":"10.1245\/s10434-023-13463-x","article-title":"Impact of primary tumor location and genomic alterations on survival following cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion for colorectal peritoneal metastases","volume":"30","author":"Hamed","year":"2023","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2026.112184_bib25","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1245\/s10434-020-09161-7","article-title":"Prognostic impact of primary side and RAS\/RAF mutations in a surgical series of colorectal cancer with peritoneal metastases","volume":"28","author":"Baratti","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2026.112184_bib26","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/SLA.0000000000002899","article-title":"Mutations of RAS\/RAF proto-oncogenes impair survival after cytoreductive surgery and HIPEC for peritoneal metastasis of colorectal origin","volume":"268","author":"Schneider","year":"2018","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.ejso.2026.112184_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/cells14030161","article-title":"Circulating tumor DNA testing for minimal residual disease and its application in colorectal cancer","volume":"14","author":"Abidoye","year":"2025","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.ejso.2026.112184_bib29","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/ans.18078","article-title":"The utility of ctDNA in colorectal cancer with peritoneal metastases","volume":"93","author":"Xue","year":"2023","journal-title":"ANZ J Surg"},{"issue":"1","key":"10.1016\/j.ejso.2026.112184_bib30","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s12029-023-00959-8","article-title":"Role of circulating tumor DNA among patients with colorectal peritoneal metastases","volume":"55","author":"Baumgartner","year":"2024","journal-title":"J Gastrointest Cancer"},{"issue":"7","key":"10.1016\/j.ejso.2026.112184_bib32","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S1470-2045(26)00085-9","article-title":"Perioperative systemic therapy versus surgery alone for resectable colorectal peritoneal-only metastases (CAIRO6): a randomised, open-label, phase 3 trial","volume":"27","author":"Rovers","year":"2026","journal-title":"Lancet Oncol"},{"issue":"7","key":"10.1016\/j.ejso.2026.112184_bib33","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1002\/cam4.1126","article-title":"Impact of postoperative complications on the colorectal cancer survival and recurrence: analyses of pooled individual patients' data from three large phase III randomized trials","volume":"6","author":"Aoyama","year":"2017","journal-title":"Cancer Med"},{"issue":"3","key":"10.1016\/j.ejso.2026.112184_bib34","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1001\/jamaoncol.2022.6911","article-title":"Association of inflammatory biomarkers with survival among patients with stage III Colon cancer","volume":"9","author":"Cheng","year":"2023","journal-title":"JAMA Oncol"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326008036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326008036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:50:48Z","timestamp":1791316248000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798326008036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":68,"alternative-id":["S0748798326008036"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2026.112184","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient selection in those undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases \u2013 systematic review and meta-analysis of prognostic factors in large cohorts","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2026.112184","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2026 Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112184"}}